|
|
|
Volumn 18, Issue 1, 2005, Pages 49-56
|
|
Chronic myelocytic leukemia--Part II: Approaches to and molecular monitoring of therapy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PROTEIN TYROSINE KINASE;
PYRIMIDINE DERIVATIVE;
RECOMBINANT INTERFERON;
BONE MARROW TRANSPLANTATION;
CHRONIC MYELOID LEUKEMIA;
DRUG ANTAGONISM;
DRUG RESISTANCE;
GENETICS;
HUMAN;
ONCOGENE;
REVIEW;
ANTINEOPLASTIC AGENTS;
BONE MARROW TRANSPLANTATION;
DRUG RESISTANCE, NEOPLASM;
FUSION PROTEINS, BCR-ABL;
GENES, ABL;
HUMANS;
INTERFERON TYPE I, RECOMBINANT;
LEUKEMIA, MYELOID, CHRONIC;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
|
|
EID: 15544378283
PISSN: 0894959X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (55)
|
